Furthermore, we think that the recent introduction of the multigene panel test could increase the rate of hereditary PrC by adding new genes to the BRCA analysis such as CHEK2, that is frequently associated with this kind of tumor, as was shown recently23. This evidence concerns the gene CHEK2 and neoplasm.